Literature DB >> 19149976

Clinical features, diagnostic techniques and management of dual dengue and malaria infection.

Amanullah Abbasi1, Nazish Butt, Qurban Hussain Sheikh, Abdul Rabb Bhutto, S M Munir, Syed Masroor Ahmed.   

Abstract

OBJECTIVE: To find out clinical features, diagnostic techniques and management outcome of patients having dual dengue and malaria infection. STUDY
DESIGN: A case series. PLACE AND DURATION OF STUDY: Medical Unit-III, Ward- 7, Jinnah Postgraduate Medical Centre, Karachi, from September 2007 to January 2008.
METHODOLOGY: Patients presented with fever of less than or equal to 10 days duration, severe body aches, rash and bleeding manifestations were included. Patients with obvious features of other diseases like typhoid, hereditary bleeding diathesis and hematological malignancies and only malarial parasite positive with high grade intermittent fever without rash and myalgia were excluded from the study. Diagnosis of dengue and malaria was based on history, clinical features, laboratory parameters and malarial parasite test by thin and thick films. Serological evaluation was done by dengue IgM and IgG by ELISA test kit. Patients were divided into three groups. Group A was dengue IgM positive plus MP positive, group B was dengue IgM positive and MP negative and group C was dengue IgM negative and MP negative and were clinically suspected dengue and malaria. The clinical manifestations and laboratory parameters of dual dengue and malaria positive patients were compared with malaria and dengue negative patients.
RESULTS: One hundred and fourteen patients were seen during the study period. Antibody titer (IgM) tested in all patients was found positive in 78 patients (69.64%). Among those 78 patients, 26 (23.21%) were concomitantly positive for malarial parasite (Group A). Plasmodium vivax was positive in 25 patients and falciparum in one patient. Fifty-two patients (46.42%) were dengue IgM positive and MP negative (Group B). Thirty four (30.35%) patients were MP and dengue IgM negative (Group C) but were strongly suspected for DHF and malaria on clinical and hematological basis. The hemoglobin of 34.61% of patients of group A, 5.76% of group B and 14.7% of group C were low, hematocrit level was also low in group A (92.3%), group B (15.38%) and group C (70.58%) patients. The platelet count was markedly low in 84.61% of patients of group A, 57.69% of group B and 94.11% of group C. Leukopenia was found in 34.61% of patients of group A, 78.84% in group B and 29.411% in group C. The liver function tests were deranged in all groups.
CONCLUSION: The frequency of dual dengue and malaria infection was 23.21%. The serology of the dengue and malaria showed negative results in 30.35%. The diagnosis of dual infections could be made on the basis of history, clinical examination supported by hematological results. It is recommended that all the patients suspected for dual infections should be treated concomitantly for dengue and malaria in malaria endemic areas.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19149976     DOI: 01.2009/JCPSP.2529

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  19 in total

1.  Malaria or flu? A case report of misdiagnosis.

Authors:  Seif Ali Mahdavi; Ahmad Raeesi; Leyla Faraji; Mohammad Reza Youssefi; Mohammad Taghi Rahimi
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

2.  Clinical profile of concurrent dengue fever and Plasmodium vivax malaria in the Brazilian Amazon: case series of 11 hospitalized patients.

Authors:  Belisa M L Magalhães; Márcia A A Alexandre; André M Siqueira; Gisely C Melo; João B L Gimaque; Michele S Bastos; Regina M P Figueiredo; Ricardo C Carvalho; Michel A Tavares; Felipe G Naveca; Pedro Alonso; Quique Bassat; Marcus V G Lacerda; Maria P G Mourão
Journal:  Am J Trop Med Hyg       Date:  2012-10-01       Impact factor: 2.345

3.  Prediction of dengue disease severity among pediatric Thai patients using early clinical laboratory indicators.

Authors:  James A Potts; Robert V Gibbons; Alan L Rothman; Anon Srikiatkhachorn; Stephen J Thomas; Pra-On Supradish; Stephenie C Lemon; Daniel H Libraty; Sharone Green; Siripen Kalayanarooj
Journal:  PLoS Negl Trop Dis       Date:  2010-08-03

4.  A case of cerebral malaria and dengue concurrent infection.

Authors:  Anwar Alam; Md Dm
Journal:  Asian Pac J Trop Biomed       Date:  2013-05

5.  An 11-year-old boy with Plasmodium falciparum malaria and dengue co-infection.

Authors:  Satja Issaranggoon na ayuthaya; Anchalee Wangjirapan; Peninnah Oberdorfer
Journal:  BMJ Case Rep       Date:  2014-04-01

6.  Is dengue and malaria co-infection more severe than single infections? A retrospective matched-pair study in French Guiana.

Authors:  Loïc Epelboin; Matthieu Hanf; Philippe Dussart; Sihem Ouar-Epelboin; Félix Djossou; Mathieu Nacher; Bernard Carme
Journal:  Malar J       Date:  2012-05-01       Impact factor: 2.979

7.  Concurrent infection of dengue fever and hepatitis A infection: A case report.

Authors:  Syed Ahmed Zaki; Vijay Lad
Journal:  Indian J Crit Care Med       Date:  2011-10

Review 8.  Etiology of Severe Febrile Illness in Low- and Middle-Income Countries: A Systematic Review.

Authors:  Namrata Prasad; David R Murdoch; Hugh Reyburn; John A Crump
Journal:  PLoS One       Date:  2015-06-30       Impact factor: 3.240

9.  Malaria and dengue in Hodeidah city, Yemen: High proportion of febrile outpatients with dengue or malaria, but low proportion co-infected.

Authors:  Rashad Abdul-Ghani; Mohammed A K Mahdy; Sameer Alkubati; Abdullah A Al-Mikhlafy; Abdullah Alhariri; Mrinalini Das; Kapilkumar Dave; Julita Gil-Cuesta
Journal:  PLoS One       Date:  2021-06-25       Impact factor: 3.240

10.  Severe falciparum malaria with dengue coinfection complicated by rhabdomyolysis and acute kidney injury: an unusual case with myoglobinemia, myoglobinuria but normal serum creatine kinase.

Authors:  Kok Pin Yong; Ban Hock Tan; Chian Yong Low
Journal:  BMC Infect Dis       Date:  2012-12-20       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.